Cargando…

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review

BACKGROUND: Second-line drug resistance (SLD) among tuberculosis (TB) patients is a serious emerging challenge towards global control of the disease. We characterized SLD-resistance conferring-mutations among TB patients with rifampicin and/or isoniazid (RIF and/or INH) drug-resistance tested at the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mujuni, Dennis, Kasemire, Dianah Linda, Ibanda, Ivan, Kabugo, Joel, Nsawotebba, Andrew, Phelan, Jody E., Majwala, Robert Kaos, Tugumisirize, Didas, Nyombi, Abdunoor, Orena, Beatrice, Turyahabwe, Irene, Byabajungu, Henry, Nadunga, Diana, Musisi, Kenneth, Joloba, Moses Lutakoome, Ssengooba, Willy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003953/ https://www.ncbi.nlm.nih.gov/pubmed/35410160 http://dx.doi.org/10.1186/s12879-022-07339-w

Ejemplares similares

Effectiveness of thermal screening in detection of COVID-19 among truck drivers at Mutukula Land Point of Entry, Uganda
por: Nsawotebba, Andrew, et al.
Publicado: (2021)

Impact of randomized blinded rechecking program on the performance of the AFB Microscopy Laboratory Network in Uganda: a decadal retrospective study
por: Nsawotebba, Andrew, et al.
Publicado: (2023)

Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda
por: Kabugo, Joel, et al.
Publicado: (2023)

Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
por: Bahizi, Gloria, et al.
Publicado: (2021)

Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory
por: Kabugo, Joel, et al.
Publicado: (2021)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
por: Kabahita, Jupiter Marina, et al.
Publicado: (2022)

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016)

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
por: Lukoye, Deus, et al.
Publicado: (2015)

Quality of Sputum Specimen Samples Submitted for Culture and Drug Susceptibility Testing at the National Tuberculosis Reference Laboratory-Uganda, July-October 2013
por: Bulage, Lilian, et al.
Publicado: (2015)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting: A mixed methods study
por: Muchuro, Simon, et al.
Publicado: (2022)

Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey
por: Lukoye, Deus, et al.
Publicado: (2013)

Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania
por: Nyombi, Balthazar M, et al.
Publicado: (2008)

Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)
por: Kateete, David Patrick, et al.
Publicado: (2019)

Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
por: Bwanga, Freddie, et al.
Publicado: (2009)

Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis
por: Wang, Linfeng, et al.
Publicado: (2023)

Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing
por: Ssengooba, Willy, et al.
Publicado: (2018)

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Evaluating the effectiveness of Uganda’s Supranational TB Reference Laboratory quality management system training program
por: Dorothy, Nakiwala, et al.
Publicado: (2023)

Effects of demand-side incentives in improving the utilisation of delivery services in Oyam District in northern Uganda: a quasi-experimental study
por: Massavon, William, et al.
Publicado: (2017)

Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers
por: Muttamba, Winters, et al.
Publicado: (2020)

Is aggregated surveillance data a reliable method for constructing tuberculosis care cascades? A secondary data analysis from Uganda
por: White, Elizabeth B., et al.
Publicado: (2022)

Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda
por: Kasozi, Samuel, et al.
Publicado: (2020)

Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2022)

Drug resistance and combating drug resistance in cancer
por: Wang, Xuan, et al.
Publicado: (2019)

TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2022)

Measles outbreak propagated by children congregating at water collection points in Mayuge District, eastern Uganda, July – October, 2016
por: Majwala, Robert Kaos, et al.
Publicado: (2018)

Using dried blood spots collected under field condition to determine HIV-1 diversity and drug resistance mutations in resource limited Tanzania
por: Kimaro, James, et al.
Publicado: (2014)

Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis
por: Portelli, Stephanie, et al.
Publicado: (2018)

Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance
por: Hodel, Eva Maria, et al.
Publicado: (2009)

Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2023)

Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study
por: Baluku, Joseph Baruch, et al.
Publicado: (2021)

Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda
por: Makabayi-Mugabe, Rita, et al.
Publicado: (2023)

Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole
por: Campos, Mônica C., et al.
Publicado: (2017)

Correction: Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study
por: Baluku, Joseph Baruch, et al.
Publicado: (2023)

Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection
por: Lukoye, Deus, et al.
Publicado: (2011)

Drug hypersensitivity in drug-resistant tuberculosis
por: Katran, Zeynep Yegin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vilcq6t413abrjisi593d37t0c